Optimising Computerised Decision Support To Transform Medication Safety And Reduce Prescriber Burden
Funder
National Health and Medical Research Council
Funding Amount
$325,546.00
Summary
As medication management in Australian hospitals shifts from paper to electronic formats, organisations are faced with a difficult decision: should drug-drug interaction (DDI) alerts be turned on and if so, which alerts? In this study, we propose a highly innovative approach to assess DDI alerts, which combines a robust evaluation of error rates with a human factors evaluation of alerts.
Enhancing Treatment Of Hepatitis C In Opioid Substitution Settings II (ETHOS II): A Partnership Project To Enhance Hepatitis C Care In Drug And Alcohol Clinics
Funder
National Health and Medical Research Council
Funding Amount
$1,265,716.00
Summary
This Partnership Project will evaluate novel strategies to enhance care for hepatitis C infection in drug and alcohol clinics. Based on a foundation of strong, existing partnerships, this project has considerable potential to facilitate the translation of research outcomes into policy and practice and facilitate the scale-up of hepatitis C care in drug and alcohol clinics in NSW and nationally.
Prevention And Treatment Of Viral Hepatitis Amongst Prisoners
Funder
National Health and Medical Research Council
Funding Amount
$1,102,510.00
Summary
Hepatitis B and C infection rates remain very high in some Australian populations, notably prisoners. As this group cycles frequently back to the general community, prevention of transmission is critical. Antiviral treatment uptake remains very low in Australia, yet the prison environment offers a unique opportunity to address this. This project aims to assess effectiveness of existing prevention strategies, guide new control measures, and to evaluate a novel nurse-led model for treatment.